Court approves settlement of Clover Health derivative suits, dismisses cases with prejudice

CLOVER HEALTH INVESTMENTS, CORP. /DE

Court approved settlement of four consolidated shareholder derivative actions against Clover and its directors.
Settlement provides for dismissal with prejudice, release of claims, and no admission of liability.
Court awarded $2.5M in plaintiffs' counsel fees and expenses, plus $3,000 service awards to seven plaintiffs.
Final judgment entered July 16, 2024; derivatives cases included in Tennessee, Delaware, and New York.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.